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Abstract Tinnitus is a frequent and often debilitating condition. There is consensus in the 
scientific community that there exist various forms of tinnitus, which differ in their 
pathogenesis. 
Here we report a series of five cases where the onset of tinnitus was associated with 
viral infections. In all five patients elevated antibodies against Coxsackie B have 
been detected. This observation suggests that Coxsackie B Virus infections might 
be involved in the development of some cases of tinnitus and indicate that further 







Tinnitus, the perception of a sound in the ab-
sence of external acoustic stimulation is a common 
phenomenon disturbing millions of individuals 
worldwide [1]. Even if the pathophysiology of tin-
nitus is not entirely known, there is considerable 
evidence that altered input from the peripheral au-
ditory system can result in reorganization of central 
nervous system structures (auditory, but also limbic 
areas), which may lead to neuronal signals that 
cause phantom sensations [2]. Very often tinnitus 
is related to hearing disorders such as presbyacusis, 
noise trauma or sudden hearing loss. In addition, 
alterations of peripheral auditory function have 
also been shown to occur as a symptom of a wide 
range of viral infections [3–5] with best evidence 
for varizella zoster [6,7]. Support for a potential 
relationship between viral infections and tinnitus 
comes from clinical experience with a frequently 
reported temporal connection between onset of 
tinnitus and influenzal infections. Here we report a 
series of five cases which suggest the involvement of 
a viral infection with Coxsackie B in the pathogen-
esis of subjective tinnitus. 
CASE rEporTS
One of the authors had suffered a viral meningo-
encephalitis with pleocytosis in the cerebrosopinal 
fluid (CSF) more than 50 years ago. At that time 
neither serum nor CSF were investigated for specific 
antibodies. During the course of this meningoen-
cephalitis a unilateral, narrow band high frequency 
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tinnitus developed, which worsened over the following 
decades. There was no subjective hearing impairement 
and audiological exams were normal. Several decades 
later an elevated titter of IgG antibodies against Coxsackie 
B was detected. 
During his work as a occupational health practitioner 
one of the authors (H.S.) witnessed the occurrence of 
tinnitus in four employees over a short period of time. 
These four employees worked closely together in the same 
building and all of them reported that tinnitus occurred 
after they had suffered an influenza with headache, 
muscle aches and fever. None of the patients complained 
about hearing loss. Serological screening revealed typical 
findings of an acute Coxsackie B infection with elevated 
antibody titters in all four patients. In none of them tin-
nitus improved during the following weeks, in spite of 
inpatient treatment in the local ENT department.
dISCuSSIon
Here we report the occurrence of tinnitus associated 
with influenzal infections in four patients which worked 
closely together and one case of tinnitus occurring after 
viral meningoencephalitis. In all five patients elevated 
antibodies against Coxsackie B have been detected. We 
are aware that a causal relationship between the infection 
with Coxsackie B and tinnitus cannot be proofed by this 
observation. Furthermore, the polymerase chain reaction 
(PCR) technique for the detection of enterovirus gene 
sequences was not available at that time.
Nevertheless it is highly probable, that all five patients 
experienced tinnitus as a consequence of a Coxsackie B 
infection. Recently, sudden deafness has been reported 
as a symptom of enterovirus meningitis [8]. A systematic 
study which used PCR for virus detection in 55 consecu-
tive patients with sudden hearing loss, revealed positive 
diagnosis of enterovirus infection in 22 patients, among 
them 13 with Coxsackie B. In the majority of these pa-
tients sudden hearing loss was associated with tinnitus 
[9]. In all five cases which we describe here, tinnitus 
occurred without detectable hearing loss. However, it is 
conceivable that a viral infection, which can cause hear-
ing loss by infection of the cochlea or the auditory nerve, 
might also cause an alteration of neuronal functioning 
of the peripheral auditory system, resulting in tinnitus 
without hearing loss. In addition, a possible hearing defi-
cit in the high frequency range, not detected by routine 
audiological methods, cannot be precluded. A potential 
relationship between Coxsackie B and tinnitus is further 
supported by the expression of Coxsackie adenovirus 
receptors in the cochlea [10]. These could represent the 
structural substrate underlying the effects of Coxsackie B 
on the auditory system. 
Even if at this stage the assumption of a relationship 
between Coxsackie B Virus infections and the develop-
ment of tinnitus is largely hypothetical, our findings 
suggest that further systematic investigations are war-
ranted. The possibility that enterovirus infections may 
be associated not only with sudden hearing loss, but also 
with some hitherto “idiopathic” cases of tinnitus, should 
be recognized. The availability of highly sensitive PCR 
techniques, together with the recent development of 
pleconaril, which may be used as a specific therapy for 
enterovirus infections [11,12], highlights the importance 
of early diagnosis of enteroviruses as the cause of other-
wise idiopathic tinnitus. 
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